The Law Office of Jonathan M. Stein, P.L. is investigating the Board of Directors of Martek Biosciences Corporation (“Martek” or the “Company”) (Nasdaq: MATK) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to DSM. Under the terms of the proposed transaction, Martek shareholders are to receive $31.50 in cash for each share they own, for a total transaction value of approximately $1 billion. The investigation involves whether the Board of Directors of Martek breached their fiduciary duties to Martek stockholders by failing to adequately shop the Company before agreeing to enter into the transaction and whether Martek has disclosed all material information to shareholders about the proposed transaction. If you own stock in Martek and wish to obtain additional information about your rights, or if you have information regarding the above investigation, please contact Jonathan M. Stein, Esq. either via email at firstname.lastname@example.org or by telephone at (561) 961-2244. The Law Office of Jonathan M. Stein, P.L. represents shareholders and consumers in complex litigation, including class action and derivative litigation. More information about the firm is available through its website, www.jonathansteinlaw.com, and upon request from the firm. Jonathan M. Stein is the attorney responsible for the content of this release.